Showing results (21-30 of 661) with videos related to
Sort By:
Pageof 67
Seminars in Liver Disease|July 9, 2024
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver DiseaseMonica A Tincopa, Rohit LoombaClinical Liver Disease|December 16, 2022
Magnetic resonance imaging proton density fat fraction as an imaging-based biomarker of treatment response in patients with nonalcoholic steatohepatitisJonathan G Stine, Rohit LoombaGut|February 19, 2020
Advances in non-invasive assessment of hepatic fibrosisRohit Loomba, Leon A AdamsInfectious Disorders Drug Targets|March 12, 2009
Drug targets in hepatitis B virus infectionLance L Stein, Rohit LoombaGastroenterology|February 22, 2017
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future DirectionsRohit Loomba, T Jake LiangAntiviral Therapy|March 8, 2006
Novel approaches to new therapies for hepatitis B virus infectionRohit Loomba, T Jake LiangNature Reviews. Gastroenterology & Hepatology|February 22, 2018
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLDElliot B Tapper, Rohit LoombaMayo Clinic Proceedings|July 30, 2015
Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisErin K Spengler, Rohit LoombaThe Lancet. Gastroenterology & Hepatology|April 15, 2023
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitisMonica A Tincopa, Rohit LoombaPageof 67